Published in Oncogenesis on June 12, 2017
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature (2005) 18.30
Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science (2003) 18.29
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature (2005) 14.65
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature (2006) 11.76
An oncogene-induced DNA damage model for cancer development. Science (2008) 11.60
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature (2006) 11.18
DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet (2001) 10.77
Intrinsic tumour suppression. Nature (2004) 8.73
DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science (2000) 7.85
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol (2009) 7.74
Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell (2011) 4.83
EBV persistence in memory B cells in vivo. Immunity (1998) 4.44
Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer (2009) 4.06
Early events in Epstein-Barr virus infection of human B lymphocytes. Virology (1991) 3.60
The structural determinants of checkpoint activation. Genes Dev (2007) 3.53
Supercoiled loops and eucaryotic DNA replicaton. Cell (1980) 3.24
Activation of the cellular DNA damage response in the absence of DNA lesions. Science (2008) 3.17
Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol (1977) 3.11
Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A (2004) 3.11
A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations. Nat Struct Mol Biol (2011) 3.10
Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem (2004) 3.10
ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J (2006) 3.05
Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol (2012) 3.03
Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology (1977) 2.94
Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol Cell (2005) 2.89
EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J (1994) 2.79
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat Struct Mol Biol (2011) 2.42
ATR signalling: more than meeting at the fork. Biochem J (2011) 2.37
Replication fork movement sets chromatin loop size and origin choice in mammalian cells. Nature (2008) 2.36
Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J Virol (1991) 2.28
An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe (2010) 2.23
ATR signaling can drive cells into senescence in the absence of DNA breaks. Genes Dev (2008) 2.17
Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner. Cancer Res (2010) 1.82
A relationship between replicon size and supercoiled loop domains in the eukaryotic genome. Nature (1982) 1.80
Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep (2013) 1.74
DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol (2013) 1.72
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J (2012) 1.71
Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents. J Med Chem (2011) 1.67
Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress. Oncogene (2012) 1.48
Induction of a pro-apoptotic ATM-NF-kappaB pathway and its repression by ATR in response to replication stress. EMBO J (2008) 1.46
Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR. J Clin Invest (2011) 1.46
ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress. PLoS Genet (2009) 1.43
Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene (2009) 1.27
Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells. Oncogene (2009) 1.16
Cdc45 is a critical effector of myc-dependent DNA replication stress. Cell Rep (2013) 1.16
Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase. Mol Cell (2015) 1.08
The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia (2011) 1.00
Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus. Oncogene (2013) 0.92
STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation. Proc Natl Acad Sci U S A (2014) 0.87
4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors. Bioorg Med Chem Lett (2006) 0.83
Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest. PLoS One (2014) 0.83
Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors. Oncogene (2015) 0.81
Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization. Proc Natl Acad Sci U S A (2016) 0.79
Visualization of DNA loops in nucleoids from HeLa cells: assays for DNA damage and repair. Cytometry (1987) 0.77
Activation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells. Oncotarget (2016) 0.75